Anthracene

Anthracene

SCHEMBL10416267

O=C(O)c1ccc2ccccc2n1.c1ccc2cc3ccccc3cc2c1

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.89
▸ CNR2 P34972 3/20 0.62
▸ HDAC8 Q9BY41 1/20 0.58
▸ RAB9A P51151 3/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ NFKB1 P19838 1/20 0.57
▸ NFKB2 Q00653 1/20 0.57
▸ RELA Q04206 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.56
▸ MAPT P10636 2/20 0.56
▸ GAA P10253 1/20 0.56
▸ KDM4C Q9H3R0 1/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ HPGD P15428 3/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ TP53 P04637 1/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ KDM4E B2RXH2 5/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinaldic Acid SCHEMBL1242670 0.94 MGAM (1.00) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL29350584 0.94 MGAM (1.00) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL39024 0.94 MGAM (1.00) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL5228655 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL5228672 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL7202684 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL2372429 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL8798794 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL4588314 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2
Quinaldic Acid SCHEMBL4802724 0.92 MGAM (0.96) MGAMCNR2HDAC8RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225520-B2 Immunotherapy compositions and methods DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-01-18 — — US disclosed
US-20190256597-A1 IMMUNOTHERAPY COMPOSITIONS AND METHODS DANA-FARBER CANCER INSTITUTE, INC. (US) 2019-08-22 — — US disclosed
EP-3416686-A1 IMMUNOTHERAPY COMPOSITIONS AND METHODS Dana Farber Cancer Institute, Inc. (US) 2018-12-26 — — EP disclosed
WO-2017143094-A1 IMMUNOTHERAPY COMPOSITIONS AND METHODS DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-08-24 — — WO disclosed
US-4927865-A CURABLE EPOXY RESINS CIBA-GEIGY CORPORATION (US) 1990-05-22 — — US disclosed
US-4927865-A CURABLE EPOXY RESINS CIBA-GEIGY CORPORATION (US) 1990-05-22 — — US disclosed
US-4855084-A PHOTOSENSITIVE COMPOSITIONS CIBA-GEIGY CORPORATION (US) 1989-08-08 — — US disclosed
US-4855084-A PHOTOSENSITIVE COMPOSITIONS CIBA-GEIGY CORPORATION (US) 1989-08-08 — — US disclosed
US-4492686-A Cosmetic makeup containing colored pigments salified with amine functions SOCIETE ANONYME DITE: L'OREAL (FR) 1985-01-08 — — US disclosed
Send feedback